TRICARE coverage of weight-loss GLP-1s, by plan
| TRICARE plan | Wegovy / Zepbound for weight loss | Notes |
|---|---|---|
| TRICARE Prime, Prime Remote | Covered with prior authorization | Network prescriber; must meet clinical criteria |
| TRICARE Select | Covered with prior authorization | Same criteria; cost shares apply |
| TRICARE Young Adult | Covered with prior authorization | Same criteria |
| TRICARE Reserve Select, Retired Reserve | Covered with prior authorization | Same criteria |
| US Family Health Plan | Covered with prior authorization | Same criteria |
| Continued Health Care Benefit Program | Covered with prior authorization | Same criteria |
| TRICARE For Life | Not covered since Aug 31, 2025 | Federal law doesn't allow it; Medicare GLP-1 Bridge ($50/mo) if enrolled in Part D |
| Military-hospital-only and NATO beneficiaries | Not covered since Aug 31, 2025 | Pay full cost elsewhere |
| Any plan, type 2 diabetes | Ozempic, Mounjaro, Trulicity, Victoza covered | When medically necessary, with prior authorization |
Source: TRICARE pharmacy FAQ and TRICARE Newsroom articles on weight-loss medication coverage (tricare.mil), read Nov 3, 2026. Overseas enrollees on some plans have separate rules.
What TRICARE asks for
Coverage runs through Express Scripts, TRICARE's pharmacy contractor, and needs a prior authorization from a network prescriber showing you meet the clinical criteria: in practice a qualifying BMI and weight-related conditions, plus renewal with documented progress. Approval isn't permanent; plan on re-qualifying.
Since the August 2025 change, TRICARE revised these criteria for everyone, so a prescription that was approved years ago may need a new authorization.
TRICARE For Life: what changed and what to do
TRICARE For Life members lost weight-loss drug coverage on Aug 31, 2025, even with an approved prior authorization, because federal law doesn't let TFL pay for drugs prescribed mainly for weight loss. Express Scripts sent letters 30 days ahead.
The new route is Medicare: from Jul 1, 2026 to Dec 31, 2027, the Medicare GLP-1 Bridge covers Wegovy, the Wegovy pill, the Zepbound KwikPen and Foundayo for $50 a month for people who enroll in Part D and meet CMS's BMI rules. TFL members without Part D would have to enroll to use it.
Paying without TRICARE
If your plan won't cover it or approval is slow, online programs don't bill TRICARE at all. Compounded semaglutide starts at $59 a month and compounded tirzepatide at $96 (Nov 12, 2026). Brand-name Wegovy at online programs starts at $273 at Ro, and Zepbound at $373. HSA and FSA cards are accepted at HumeCare, Maximus, SHED, Oak.





